No significant difference of GAS5 mRNA expression level was identified in BLCA between patients with smaller tumor sizes (T1–T2 status) and patients with larger tumor sizes (T3–T4 status; Figure 1A). Here, GAS5 is linked to bladder transitional cell carcinoma.